These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC. Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301 [Abstract] [Full Text] [Related]
5. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M. Harm Reduct J; 2018 Sep 10; 15(1):46. PubMed ID: 30200991 [Abstract] [Full Text] [Related]
6. Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada. Moallef S, Nosova E, Milloy MJ, DeBeck K, Fairbairn N, Wood E, Kerr T, Hayashi K. Public Health Rep; 2019 Sep 10; 134(4):423-431. PubMed ID: 31211644 [Abstract] [Full Text] [Related]
7. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Drug Alcohol Depend; 2018 Sep 01; 190():242-245. PubMed ID: 30064061 [Abstract] [Full Text] [Related]
8. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users. Wallace B, van Roode T, Pagan F, Phillips P, Wagner H, Calder S, Aasen J, Pauly B, Hore D. Harm Reduct J; 2020 May 12; 17(1):29. PubMed ID: 32398090 [Abstract] [Full Text] [Related]
9. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking. Reed MK, Borne E, Esteves Camacho T, Kelly M, Rising KL. Harm Reduct J; 2024 Jan 30; 21(1):26. PubMed ID: 38287409 [Abstract] [Full Text] [Related]
10. Factors associated with drug checking service utilization among people who use drugs in a Canadian setting. Long V, Arredondo J, Ti L, Grant C, DeBeck K, Milloy MJ, Lysyshyn M, Wood E, Kerr T, Hayashi K. Harm Reduct J; 2020 Dec 14; 17(1):100. PubMed ID: 33317553 [Abstract] [Full Text] [Related]
11. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. Rouhani S, Park JN, Morales KB, Green TC, Sherman SG. Harm Reduct J; 2019 Jun 24; 16(1):39. PubMed ID: 31234942 [Abstract] [Full Text] [Related]
12. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study. Hayashi K, Milloy MJ, Lysyshyn M, DeBeck K, Nosova E, Wood E, Kerr T. Drug Alcohol Depend; 2018 Feb 01; 183():1-6. PubMed ID: 29220642 [Abstract] [Full Text] [Related]
13. Investigating opioid preference to inform safe supply services: A cross sectional study. Ferguson M, Parmar A, Papamihali K, Weng A, Lock K, Buxton JA. Int J Drug Policy; 2022 Mar 01; 101():103574. PubMed ID: 35007878 [Abstract] [Full Text] [Related]
14. Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City. McKnight C, Des Jarlais DC. Int J Drug Policy; 2018 Oct 01; 60():82-88. PubMed ID: 30176422 [Abstract] [Full Text] [Related]
15. Association between posttraumatic stress disorder and nonfatal drug overdose. Lee WK, Hayashi K, DeBeck K, Milloy MJS, Grant C, Wood E, Kerr T. Psychol Trauma; 2020 May 01; 12(4):373-380. PubMed ID: 31524428 [Abstract] [Full Text] [Related]
16. Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities. Morales KB, Park JN, Glick JL, Rouhani S, Green TC, Sherman SG. Drug Alcohol Depend; 2019 Nov 01; 204():107547. PubMed ID: 31536877 [Abstract] [Full Text] [Related]
17. Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada. Kennedy MC, Dong H, Tobias S, Buxton JA, Lysyshyn M, Tupper KW, Ti L. Am J Prev Med; 2024 Jan 01; 66(1):10-17. PubMed ID: 37633426 [Abstract] [Full Text] [Related]
18. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply. Shin SS, LaForge K, Stack E, Pope J, Leichtling G, Larsen JE, Leahy JM, Seaman A, Hoover D, Chisholm L, Blazes C, Baker R, Byers M, Branson K, Korthuis PT. Harm Reduct J; 2022 Jul 11; 19(1):76. PubMed ID: 35818072 [Abstract] [Full Text] [Related]
19. "We don't got that kind of time, man. We're trying to get high!": Exploring potential use of drug checking technologies among structurally vulnerable people who use drugs. Bardwell G, Boyd J, Tupper KW, Kerr T. Int J Drug Policy; 2019 Sep 11; 71():125-132. PubMed ID: 31336258 [Abstract] [Full Text] [Related]
20. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis. Baldwin N, Gray R, Goel A, Wood E, Buxton JA, Rieb LM. Drug Alcohol Depend; 2018 Apr 01; 185():322-327. PubMed ID: 29486421 [Abstract] [Full Text] [Related] Page: [Next] [New Search]